Ibrutinib is a cancer medication that interferes with the growth and spread of cancer cells in the body. Ibrutinib is used to treat mantle cell lymphoma (MCL), or chronic lymphocytic leukemia (CLL). Ibrutinib is usually given after at least one other medication has been tried without success. Ibrutinib may also be used for purposes not listed in this medication guide.
Imbruvica is a cancer medication that treats chronic lymphocytic leukemia and mantle cell lymphoma. These are types of cancers that affect the white blood cells in body. Imbruvica belongs to a class of medications known as kinase inhibitors. Imbruvica works by suppressing the growth and spread of the cancer cells in the body.